A detailed history of Private Advisor Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Private Advisor Group, LLC holds 30,721 shares of OGN stock, worth $631,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,721
Previous 25,318 21.34%
Holding current value
$631,316
Previous $475,000 33.68%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$17.45 - $21.96 $94,282 - $118,649
5,403 Added 21.34%
30,721 $635,000
Q1 2024

Apr 30, 2024

BUY
$13.78 - $18.8 $154,652 - $210,992
11,223 Added 79.62%
25,318 $475,000
Q4 2023

Feb 06, 2024

SELL
$10.95 - $17.32 $139,371 - $220,448
-12,728 Reduced 47.45%
14,095 $203,000
Q3 2023

Nov 02, 2023

BUY
$16.59 - $23.77 $464 - $665
28 Added 0.1%
26,823 $465,000
Q2 2023

Aug 09, 2023

BUY
$19.27 - $24.63 $9,962 - $12,733
517 Added 1.97%
26,795 $557,000
Q1 2023

May 10, 2023

BUY
$21.42 - $32.08 $77,561 - $116,161
3,621 Added 15.98%
26,278 $618,000
Q4 2022

Jan 18, 2023

SELL
$23.31 - $28.61 $42,727 - $52,442
-1,833 Reduced 7.48%
22,657 $0
Q3 2022

Oct 14, 2022

SELL
$23.4 - $34.25 $188,908 - $276,500
-8,073 Reduced 24.79%
24,490 $573,000
Q2 2022

Jul 13, 2022

BUY
$31.66 - $38.9 $552,118 - $678,377
17,439 Added 115.31%
32,563 $1.1 Million
Q4 2021

Feb 10, 2022

SELL
$28.67 - $37.13 $81,050 - $104,966
-2,827 Reduced 15.75%
15,124 $461,000
Q3 2021

Oct 14, 2021

SELL
$28.63 - $35.64 $20,728 - $25,803
-724 Reduced 3.88%
17,951 $589,000
Q2 2021

Aug 12, 2021

BUY
$28.45 - $38.0 $531,303 - $709,650
18,675 New
18,675 $565,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $5.23B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.